孟德尔随机化
生物
遗传学
孟德尔遗传
疾病
计算生物学
人口
遗传变异
表型
生物信息学
进化生物学
基因
动脉粥样硬化性心血管疾病
全基因组关联研究
遗传谱系
数量性状位点
等位基因
鉴定(生物学)
遗传(遗传算法)
遗传变异
梅德林
基因组学
作者
Susannah Selber‐Hnatiw,Katerina Trajanoska,Justin Pelletier,Chen‐Yang Su,Peyton McClelland,Daniel Taliun,Satoshi Yoshiji,Mooser,Claude Bhérer,Sirui Zhou
出处
期刊:Circulation
[Wolters Kluwer]
日期:2026-02-09
卷期号:19 (2): e005159-e005159
被引量:1
标识
DOI:10.1161/circgen.125.005159
摘要
BACKGROUND: Circulating proteins represent robust drug targets with therapeutic potential. Many discoveries have focused on European-ancestry populations, disregarding minuscule yet substantial proteomic differences that may contribute to disease and alter drug generalizability in other ancestry groups. METHODS: Using 2-sample Mendelian randomization and colocalization, we analyzed the effects of 1562 circulating proteins on 145 cardiometabolic-centric outcomes to identify robust protein-phenotype associations in African-ancestry populations and reveal African-ancestry associations with heterogeneous effects. We further replicated these findings using the proteomic data available from the UK Biobank Pharma Proteomics Project and tested the effect of protein quantity in association with select phenotypes. Population branch statistics were also constructed to examine whether protein-genetic instruments under natural selection could lead to significant protein-outcome associations specific to the African ancestry. RESULTS: We identified 115 robust protein target-outcome associations in African-ancestry populations. Among these, 51 demonstrated heterogeneous effects between African- and European-ancestry populations. We further replicated 4 cross-platform African-ancestry associations in the UK Biobank Pharma Proteomics Project and also revealed 4 significant, direct associations between protein levels and phenotypes. Ultimately, based on our prioritization criteria, we found that CD36 (glycoprotein IIIb), APOC1 (apolipoprotein C1), GSTA1 (glutathione S-transferase alpha 1), and FOLH1 (folate hydrolase 1) were shown to influence lipids and heart diseases, and were uniquely represented in African-ancestry populations. In addition, using population branch statistics, we showed that 47.5% of the 115 significant protein-outcome associations were possibly driven by cis -acting protein quantitative trait loci under natural selection. CONCLUSIONS: Multiple lines of evidence were used to interrogate proteomic determinants of cardiometabolic diseases and traits in African-ancestry populations. We highlighted actionable circulating protein targets that could represent potential drug targets for cardiovascular diseases specific to populations with African ancestry.
科研通智能强力驱动
Strongly Powered by AbleSci AI